Nifty 50
- Eternal₹317.4012.95 (4.25%)
- Shriram Finance₹865-35.90 (-3.98%)
- Apollo Hospitals₹7,730125.50 (1.65%)
- Adani Enterprises₹2,477-73.00 (-2.86%)
- ONGC₹227.502.50 (1.11%)
- JSW Steel₹1,185.50-34.50 (-2.83%)
- Asian Paints₹2,30722.20 (0.97%)
- Jio Financial ₹205.03-5.77 (-2.74%)
- TCS₹2,53023.10 (0.92%)
- Tata Steel₹167.67-4.66 (-2.70%)
- UltraTech Cement₹11,05092.00 (0.84%)
- Adani Ports₹1,702.70-47.30 (-2.70%)
- Maruti Suzuki₹11,23060.00 (0.54%)
- Tech Mahindra₹1,790-39.10 (-2.14%)
- Cipla₹1,3387.10 (0.53%)
- Tata Motors PV₹264.60-5.40 (-2.00%)
- Reliance Industries₹1,1905.50 (0.46%)
- Hindalco Industries₹869.85-15.75 (-1.78%)
- Axis Bank₹1,217.505.50 (0.45%)
- Trent₹2,727.50-48.30 (-1.74%)
- Offerings
- Tools & Platforms
Tools & Calculators
- Open API
- Calculators
- SIP Calculator
- CAGR Calculator
- Compound Interest Calculator
- FD Calculator
- RD Calculator
- EPF Calculator
- Retirement Calculator
- HDFC SIP Calculator
- Mutual Fund Return Calculator
- Lumpsum Calculator
- Step Up SIP Calculator
- ETF SIP Calculator
- Brokerage Calculator
- Equity Margin Calculator
- SWP Calculator
- EMI Calculator
- MTF Calculator
- Margin Pledge Calculator
- Algo Strategy
- Markets
Stocks
F&O
Mutual Funds
- More
Open Free Demat Account
Open Free Demat Account
Ambalal Sarabhai Share Price Today
As of 23-10-2026 03:44, Ambalal Sarabhai Enterprises Ltd. share price today is ₹0, with a change of ₹-36.28 (-100.00%) from the previous close of ₹36.28. The stock opened at ₹36.05 and traded between ₹34.47 and ₹36.05, with a total traded volume of 21894 shares. The company has a market capitalization of ₹277.4 Cr in the Pharmaceuticals & Biotechnology sector. while its 52-week high and low are ₹49.98 and ₹23.12, respectively.
Ambalal Sarabhai Enterprises Ltd. valuation metrics include a P/E ratio of 20.5, EPS of ₹2.32, and book value of ₹1.70. Profitability indicators show ROE of 11.24%. Ambalal Sarabhai Enterprises Ltd. has reported revenue of ₹205.5 Cr and net profit of ₹13.56 Cr.
Ambalal Sarabhai Enterprises Ltd. technical indicators include Day RSI at 36.66, Day MFI at 40.83, Day ADX at 11.13. Additional indicators include Commodity Channel Index (CCI) at -166.9 and Williams %R at -95.5. Momentum indicators show Day MACD at -0.87, Day MACD Signal Line at -0.67, DayATR at 1.8. Rate of Change indicators for Ambalal Sarabhai Enterprises Ltd. include ROC125 at 9.24 and ROC21 at -6.16.
Exponential moving averages include EMA5 at ₹37.5, EMA10 at ₹38.2, EMA12 at ₹38.3, EMA20 at ₹38.9, EMA26 at ₹39.2, EMA50 at ₹39.4, EMA100 at ₹37.8, EMA200 at ₹35.8. Simple moving averages include SMA5 at ₹37.7, SMA10 at ₹38.6, SMA20 at ₹39, SMA30 at ₹39.4, SMA50 at ₹41.4, SMA100 at ₹37.6, SMA150 at ₹35.2, SMA200 at ₹33.1.
Support levels for Ambalal Sarabhai are placed at First Support ₹35.87, Second Support ₹35.47, Third Support ₹34.93. Resistance levels are seen at First Resistance ₹36.81, Second Resistance ₹37.35, Third Resistance ₹37.75. Ambalal Sarabhai Enterprises Ltd. shareholding pattern shows promoter holding at 31.36%, FII holding at 0%, DII holding at 0%, public holding at 68.62%.
Ambalal Sarabhai Performance
Price Movement
₹34.47
₹36.05
1 Year Performance
Data is not available
Markets Today
Historical Performance
Ambalal Sarabhai Fundamentals
Ambalal Sarabhai Financials
Indicator | Jun 2026 | Mar 2026 | Dec 2025 | Sep 2025 | Jun 2025 |
|---|---|---|---|---|---|
| Total Revenue | 0.54 | 1.52 | 0 | 0.79 | 1.64 |
| Operating Expense | 1.76 | 2.87 | 0.94 | 2.42 | 2.82 |
| Operating Profit | -1.22 | -1.35 | -0.94 | -1.63 | -1.18 |
| Depreciation | 0.02 | 0.02 | 0.02 | 0.02 | 0.02 |
| Interest | 0.17 | 0.17 | 0.09 | 0.08 | 0.07 |
| Tax | 0.26 | -1.04 | -0.01 | 0 | 0 |
| Net Profit | 0.03 | 2.65 | 1.84 | -0.38 | 6.88 |
Ambalal Sarabhai Technicals
Ambalal Sarabhai Enterprises Ltd. EMA & SMA
₹34.51
↗ Bullish Moving Average
3
↘ Bearish Moving Average
13
Ambalal Sarabhai Support and Resistance
Resistance
Support
Technical Indicators
About Ambalal Sarabhai Share Price
Ambalal Sarabhai Enterprises is part of India’s long-standing business landscape, with operations connected to pharmaceuticals, electronics, and engineering through its subsidiaries and investments. When analysts review the Ambalal Sarabhai share 2025-2026, they focus on assessing the value of its legacy assets along with its ongoing partnerships and business interests. Market participants often monitor the Ambalal Sarabhai live share price to stay informed about short-term movements that may arise from company developments or announcements. For those looking at longer holding periods, studying the Ambalal Sarabhai Share Trend helps in understanding how the company’s value has evolved over time. The Ambalal Sarabhai stock quote provides a quick snapshot of current market perception regarding its overall asset base and operations.
Investors regularly track the Ambalal Sarabhai share price to evaluate whether the combined value of its businesses and holdings is reflected in the market. The Ambalal Sarabhai market price is often compared with its historical book value to assess relative valuation. Observing the Ambalal Sarabhai live price is useful during periods of increased activity, especially when there are updates related to subsidiaries. Over time, the Ambalal Sarabhai market cap helps position the company among other holding entities and manufacturing-based firms. Monitoring the daily Ambalal Sarabhai stock price also provides a simple indication of how the company’s financial decisions and asset management are viewed by the market.
Ambalal Sarabhai Fundamentals
1. Company Background
Ambalal Sarabhai Enterprises Limited traces its origins to the Sarabhai Group, one of India’s early industrial houses with a strong legacy in pharmaceuticals, chemicals, and engineering. The group played a significant role in India’s industrial and pharmaceutical development in the post-independence era.
Ambalal Sarabhai Enterprises Limited (ASE) emerged as part of the restructuring of the Sarabhai Group and has evolved into a diversified company with interests in pharmaceuticals, chemicals, and electronics.
The company is headquartered in Ahmedabad, Gujarat. Over time, the business has transitioned from a large-scale manufacturing-led model to a more focused structure comprising operating subsidiaries, joint ventures, and niche manufacturing businesses.
2. Company Product Lines
Ambalal Sarabhai Enterprises Limited operates through multiple subsidiaries and divisions, focusing on niche and specialized product segments:
Pharmaceuticals and APIs:
Through subsidiaries such as Sarabhai Chemicals, the group manufactures Active Pharmaceutical Ingredients (APIs) and formulations catering to domestic and international markets.
Specialty Chemicals:
The company is engaged in manufacturing fine chemicals and specialty chemical products used in pharmaceutical and industrial applications.
Electronics and Engineering:
Through its electronics division, including Synbiotics Limited, the group operates in niche electronic and engineering product segments.
The company structures its operations through subsidiaries to manage distinct business lines and associated risks.
3. Company Revenue Model
Ambalal Sarabhai Enterprises Limited operates a diversified revenue model combining manufacturing income and investment-linked earnings.
Key revenue streams include:
Pharmaceutical and Chemical Sales:
Revenue generated through subsidiaries engaged in API manufacturing, formulations, and specialty chemicals.
Dividend and Investment Income:
Income from investments, joint ventures, and group companies contributes to overall cash flows.
Other Operating Income:
Includes income from services, asset utilization, and other business activities across subsidiaries.
The company’s revenue profile reflects a mix of operating business performance and returns from investments and restructuring initiatives.
4. Geographic Presence
Ambalal Sarabhai Enterprises Limited has a geographically concentrated base in western India with broader market reach:
Headquarters:
Ahmedabad, Gujarat
Manufacturing and Operations:
Primarily located in Gujarat, leveraging the state’s established industrial ecosystem
Market Presence:
Domestic operations supported by exports through pharmaceutical and chemical businesses
The company continues to leverage its legacy infrastructure and industrial base in Gujarat for its operations.
5. Leadership
Some of the Key leaders as of Marcj 2026 are
- Jinal Shah – Chief Financial Officer
- Disha Mahesh Punjani – Company Secretary, Compliance Officer
- Kartikeya V Sarabhai – Executive Chairman
- Chaula Shastri – Whole-Time Director
- Mayur K Swedia – Independent Director
- Govindprasad Namdeo – Independent Director
- Brijesh Khandelwal – Independent Director
- Pushpa Robin – Independent Director
- Bharatendu Jani – Non-Executive Director
- Ajay Mayor – Non-Executive Director
- Satyen Dave – Independent Director
- Mohal Kartikeya Sarabhai – Managing Director
- Disha Mahesh Punjani – Company Secretary & Compliance Officer
6. Key Milestones
- 1970s: Reorganization of Sarabhai Group businesses, leading to the formation of Ambalal Sarabhai Enterprises Limited as a key entity
- 1980s: Expansion in pharmaceuticals, bulk drugs, and chemicals, establishing a strong industrial presence
- 2000s: Strategic restructuring and rationalization of business operations, with increased focus on subsidiaries and niche segments
- Recent Years: Continued emphasis on value unlocking through subsidiaries, operational restructuring, and strengthening of pharmaceutical and specialty chemical businesses
7. Industry Perspective
The Indian pharmaceutical and specialty chemical sectors thrive on a rapidly growing global demand for affordable alternatives. A deeper look at the industrial outlook shows a clear pivot towards companies that can provide secure, China-independent supply chains. Companies with established manufacturing footprints and FDA compliance benefit immensely from this macro shift. Adapting to fast-changing environmental regulations remains the biggest hurdle for legacy chemical firms. For investors, seeing a holding company successfully revive an old manufacturing asset strongly influences the Ambalal Sarabhai share price. In conclusion, the ability to navigate complex regulatory turnarounds directly impacts the Ambalal Sarabhai stock price.
Ambalal Sarabhai Stock Market Presence – Listing and Index Representation
Ambalal Sarabhai Enterprises is listed on the Bombay Stock Exchange (BSE) under Scrip Code: 500008. Investors and analysts refer to exchange data to track the Ambalal Sarabhai share price and understand trading patterns. Market participants also review trading volumes to identify periods of increased buying or selling interest. The company is not included in major benchmark indices such as the Nifty 50, Sensex, Nifty Midcap 100, or Nifty Smallcap 100 due to its classification as a micro-cap entity with a holding company structure. Despite this, consistent observation of the Ambalal Sarabhai share price helps reflect investor interest in companies with diversified assets and restructuring potential.
Ambalal Sarabhai Stock Performance and Share Price History
The Ambalal Sarabhai performance has been influenced by internal restructuring activities, asset sales, and developments within its subsidiaries. Historical price trends show that changes in the Ambalal Sarabhai stock price often correspond with the resolution of financial or legal matters and updates on business operations. Reviewing past data helps explain how the company’s valuation has responded to specific events over time. The Ambalal Sarabhai share price may experience periods of volatility, which traders monitor using technical tools and price charts. The Ambalal Sarabhai live price is especially relevant for those making short-term decisions. Over longer durations, the movement of the Ambalal Sarabhai stock price is linked to the performance of its active investments and joint ventures.
Ambalal Sarabhai Investor Relevance and Role in Portfolio
The investment approach for Ambalal Sarabhai Enterprises often involves assessing the combined value of its assets relative to its market valuation. Investors examine the Ambalal Sarabhai share price to determine whether the company is trading below its estimated asset value. Monitoring management decisions, including the treatment of minority shareholders, is an important part of this evaluation. The Ambalal Sarabhai P/E ratio is considered along with other measures, though price-to-book value is frequently used due to the nature of its holdings. Earnings contributions from its pharmaceutical-related businesses support continued interest from certain investor groups. The Ambalal Sarabhai share price is also followed during intraday sessions by traders who track price movements and liquidity.
Ambalal Sarabhai Sectoral Relevance and Peer Positioning
Ambalal Sarabhai Enterprises operates as a diversified holding entity with connections to multiple sectors, which distinguishes it from companies focused on a single industry. Its subsidiaries contribute to areas such as chemicals and pharmaceuticals, where it competes with other firms for business opportunities, including export markets. A structured comparison with peers shows that the company’s value is influenced by its asset base as well as the progress of its restructuring process. The Ambalal Sarabhai share price often reflects overall market sentiment toward companies with similar structures. Evaluations of strengths and risks highlight asset backing as a key factor, while delays in restructuring or legal matters may affect performance.
Summary
Ambalal Sarabhai Enterprises represents a combination of legacy assets and ongoing business interests within a listed holding company structure. The Ambalal Sarabhai share price, along with indicators such as market cap and stock price trends, helps investors understand how the market values its diversified portfolio. Its presence on the BSE provides transparency in pricing and trading activity, even though it is not part of major indices. Reviewing historical performance, valuation metrics, and sector positioning offers a clearer picture of its role in the market. Regular tracking of the Ambalal Sarabhai stock price supports informed observation of its financial and operational developments.
Ambalal Sarabhai Shareholding Pattern
| Held By | Jun 2025 | Sep 2025 | Dec 2025 | Mar 2026 | Jun 2026 | Sep 2026 |
|---|---|---|---|---|---|---|
| Promoter | 31.4 | 31.4 | 31.4 | 31.4 | 31.4 | 31.4 |
| FII | 0.4 | 0.3 | 0.3 | 0 | 0 | 0 |
| DII | 0 | 0 | 0 | 0 | 0 | 0 |
| Public | 68.3 | 68.3 | 68.3 | 68.6 | 68.6 | 68.6 |
Ambalal Sarabhai Delivery And Volume
| Period | Combined Delivery Volume | NSE+BSE Traded Volume Avg | Daily Avg Delivery Volume % |
|---|---|---|---|
| Day | 40.47 K | 40.47 K | 100.00% |
| Week | 51.35 K | 51.35 K | 100.00% |
| 1 Month | 50.63 K | 50.63 K | 100.00% |
| 6 Month | 1.03 L | 1.62 L | 63.46% |
Ambalal Sarabhai SWOT Analysis
30 Day SMA crossing over 200 Day SMA, and current price greater than open
Mid-range Performer (DVM)
Relative Outperformance versus Industry over 1 Month
Rising Net Cash Flow and Cash from Operating activity
Annual Profit Growth higher than Sector Profit Growth
Relative Outperformance versus Industry over 1 Month
Effectively using its capital to generate profit - RoCE improving in last 2 years
Companies with Low Debt
Book Value per share Improving for last 2 years
Companies with Zero Promoter Pledge
Volume Shockers
Stocks Outperforming their Industry Price Change in the Quarter
Ambalal Sarabhai Corporate Action
Ex-Date | Dividend Amount | Dividend Type | Record Date | Instrument Type |
|---|---|---|---|---|
| No Record Found | ||||
Ambalal Sarabhai Stock Comparison
Financials | ||||||
|---|---|---|---|---|---|---|
| Price (₹) | ₹141.60 | ₹29.98 | ₹456 | ₹149 | ₹274.30 | ₹55.34 |
| % Change | 3.21% | 0.00% | 1.00% | 0.00% | -3.07% | -5.00% |
| Revenue TTM (₹ Cr) | - | - | ₹526.28 | - | - | ₹1.93 |
| Net Profit TTM (₹ Cr) | - | - | ₹20.77 | - | - | ₹-0.34 |
| PE TTM | 16.90 | 7.00 | 96.10 | 10.00 | 42.10 | -103.30 |
| 1 Year Return | 15.18 | 1194.44 | ||||
| ROCE | - | - | 3.56 | - | - | - |
Similar Stocks
VIVIMEDLAB
Vivimed Labs Ltd.
₹ 6.09
-3.79%
APPL
Aptus Pharma Ltd.
₹ 491.50
-1.99%
AMANTA
Amanta Healthcare Ltd.
₹ 163.50
-0.84%
AHCL
Anlon Healthcare Ltd.
₹ 25.56
+4.97%
PATELCHEM
Patel Chem Specialities Ltd.
₹ 137.55
-4.68%
APL
Asston Pharmaceuticals Ltd.
₹ 130.12
+4.99%
AMRUTANJAN
Amrutanjan Health Care Ltd.
₹ 486.35
-2.14%
ASTONEALAB
Astonea Labs Ltd.
₹ 323.00
+0.00%
AMWILL
Amwill Health Care Ltd.
₹ 44.99
+2.83%
VALIANTLAB
Valiant Laboratories Ltd.
₹ 128.43
-2.00%
SHELTER
Shelter Pharma Ltd.
₹ 44.65
-5.00%
TLL
Trident Lifeline Ltd.
₹ 410.00
+3.99%
DPL
Dipna Pharmachem Ltd.
₹ 3.89
-1.02%
ACHYUT
Achyut Healthcare Ltd.
₹ 6.96
+4.98%
SIGACHI
Sigachi Industries Ltd.
₹ 25.06
-3.43%
WINDLAS
Windlas Biotech Ltd.
₹ 871.00
-3.27%
VINEETLAB
Vineet Laboratories Ltd.
₹ 36.50
-1.86%
CBPL
Chandra Bhagat Pharma Ltd.
₹ 39.00
-2.50%
CHCL
Cian Healthcare Ltd.
₹ 30.36
+1.98%
SOLARA
Solara Active Pharma Sciences Ltd.
₹ 612.30
-1.09%
RAJNISH
Rajnish Wellness Ltd.
₹ 0.34
+0.00%
ZIMLAB
Zim Laboratories Ltd.
₹ 126.00
-4.63%
BPLPHARMA
Bharat Parenterals Ltd.
₹ 1655.00
-7.49%
MEDICO
Medico Remedies Ltd.
₹ 20.48
-0.10%
FAQ's on AMBALALSA
What is the current share price of Ambalal Sarabhai Enterprises Ltd.?
What is the Market Capitalization of Ambalal Sarabhai Enterprises Ltd.?
What are the PE and PB ratios for Ambalal Sarabhai Enterprises Ltd.?
What is the 52-Week High and Low for Ambalal Sarabhai Enterprises Ltd.?
Who are the major shareholders of Ambalal Sarabhai Enterprises Ltd.?
Who are the peers of Ambalal Sarabhai Enterprises Ltd. in the Pharmaceuticals & Biotechnology sector?
By signing up I certify terms, conditions & privacy policy

